---
title: "HALEON UK HOLDINGS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137
json: https://whiteintel.dev/api/public/dossier/9a9412c4-bbf0-545c-b128-d5eba5dc2137
identifier: oo:GB-COH-08998608
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HALEON UK HOLDINGS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-08998608`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9a9412c4-bbf0-545c-b128-d5eba5dc2137  

## Cross-source identity

The same real-world entity, resolved across sources:

- **Glaxosmithkline Consumer Healthcare Holdings Limited** — source · `gb-coh:8998608` — https://whiteintel.dev/entity/84ddff00-3c64-4b50-ae4b-d1ba198ec5a8
- **HALEON UK HOLDINGS LIMITED** — GLEIF · `lei:549300QZEWI02JKJJW94` — https://whiteintel.dev/entity/5be01209-ee41-5b60-a070-1b998c8d4a26

## Ownership & control

### Owners / controllers

- **HALEON PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/bb4d63a2-6f20-513c-9720-d84ddf23c40c
- **GSK PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/1762d23b-34db-570b-8bff-995440dc2249
- **GLAXOSMITHKLINE HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/1b09cde5-f6d4-5e22-baf7-e2a3fc3eac6d
- **SETFIRST LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/c3d8f5a8-81f6-5054-8112-e2ec1616323f
- **GLAXOSMITHKLINE FINANCE PLC** (beneficial owner) — 100% — https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850
- **HALEON INTERMEDIATE HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d68afbda-270f-555e-98bb-654b168ad6ec
- **GLAXOSMITHKLINE FINANCE PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850
- **Novartis Holding Ag** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/74adf261-3d63-4ed2-9b54-a073bcceaf7d
- **Setfirst Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/b2825d29-b940-410d-8d9b-0af637177e29
- **GSK PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/1762d23b-34db-570b-8bff-995440dc2249
- **GLAXOSMITHKLINE HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/1b09cde5-f6d4-5e22-baf7-e2a3fc3eac6d
- **HALEON PLC** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bb4d63a2-6f20-513c-9720-d84ddf23c40c
- **HALEON INTERMEDIATE HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d68afbda-270f-555e-98bb-654b168ad6ec

### Holdings / subsidiaries

- **HALEON UK TRADING LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/09529589-094a-5a31-b815-8b27019d7e3b
- **HALEON UK IP LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e
- **HALEON UK SERVICES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/b8fdfc2e-dc0a-5a6e-bda2-a8d9b9bda7cf
- **HALEON UK RESEARCH LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/c5b503f5-4304-52d9-9d03-6db3f0085461
- **HALEON UK IP (NO. 2) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/4b38a61b-89c6-51be-ae3f-bebcfd87ec7a
- **GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) (NO.1) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/27ef8b72-824a-52cb-9600-71a727b632cf
- **HALEON UK HOLDINGS (NO.3) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d15b7551-f682-5c8c-8bbb-508f2e15ec56
- **HALEON UK HOLDINGS (NO.2) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/8da09ad2-26aa-537f-a7c7-30f14a394fc8
- **HALEON UK HOLDINGS (NO.2) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/8da09ad2-26aa-537f-a7c7-30f14a394fc8
- **HALEON UK HOLDINGS (NO.3) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d15b7551-f682-5c8c-8bbb-508f2e15ec56

### UBO chain (walk to the ultimate owner)

A **34-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `08998608`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2014-04-15
- **Registered office:** Building 5, First Floor, The Heights, Weybridge, KT13 0NY, England
- **SIC:** 64209

### Officers

- [HALEON UK CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/4c06b7f0-3494-5cca-b8a0-ef07bd339a85) — corporate secretary · appointed 2022-07-18
- EL ANSARI, Khalid — director · British · appointed 2024-09-10
- [HALEON UK CORPORATE DIRECTOR LIMITED](https://whiteintel.dev/entity/231d146c-46f2-5ffb-80c7-3e2fcb69af60) — corporate director · appointed 2022-07-18
- [HALEON UK CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/4c06b7f0-3494-5cca-b8a0-ef07bd339a85) — corporate director · appointed 2022-07-18
- [EDINBURGH PHAMACEUTICAL INDUSTRIES LIMITED](https://whiteintel.dev/entity/4401174d-4f25-5698-8e3a-3f933dd54455) — corporate secretary · appointed 2015-02-27 · resigned 2022-07-18
- BAERT, Steven Loedwijk Margareta Katrien — director · Belgian · appointed 2015-03-02 · resigned 2018-05-24
- BLACKBURN, Paul Frederick — director · British · appointed 2014-04-15 · resigned 2015-03-02
- BOURGEOIS, Scott Christopher — director · British,American · appointed 2022-07-18 · resigned 2026-03-24
- BOX, Jonathan Wilson — director · British · appointed 2015-03-02 · resigned 2017-09-30
- CONNOR, Roger — director · British · appointed 2017-04-03 · resigned 2018-06-04
- DINGEMANS, Simon Paul — director · British · appointed 2015-03-02 · resigned 2019-05-08
- GODINO ESCOLAR, Mariano Jesus — director · British · appointed 2022-05-23 · resigned 2024-10-09
- HESTLER, Tobias Hannes — director · German,Swiss · appointed 2017-10-01 · resigned 2019-12-31
- KIRSCH, Harry Werner — director · German · appointed 2015-03-02 · resigned 2018-05-24
- LIMA, Augusto — director · American · appointed 2017-06-06 · resigned 2018-05-24
- LYNCH, Ciara Martha — director · Irish · appointed 2020-03-02 · resigned 2022-07-18
- MACKAY, Iain James — director · British · appointed 2019-04-08 · resigned 2019-09-03
- MCNAMARA, Brian James — director · American · appointed 2015-03-02 · resigned 2019-09-03
- REDFERN, David Simon — director · British · appointed 2015-03-02 · resigned 2019-09-03
- SCARLETT-SMITH, Roger Lidderdale — director · British · appointed 2015-03-02 · resigned 2016-09-06

### Beneficial owners (Persons with Significant Control)

- [Haleon Intermediate Holdings Limited](https://whiteintel.dev/entity/d68afbda-270f-555e-98bb-654b168ad6ec) — 75–100% shares · corporate PSC · England — since 2023-02-06
- [Haleon Plc](https://whiteintel.dev/entity/bb4d63a2-6f20-513c-9720-d84ddf23c40c) — 75–100% shares · corporate PSC · England — ceased 2023-02-06
- [Gsk Plc](https://whiteintel.dev/entity/1762d23b-34db-570b-8bff-995440dc2249) — 75–100% shares · corporate PSC · England — ceased 2022-07-15
- [Glaxosmithkline Holdings Limited](https://whiteintel.dev/entity/1b09cde5-f6d4-5e22-baf7-e2a3fc3eac6d) — 75–100% shares · corporate PSC · England — ceased 2019-06-24
- [Glaxosmithkline Finance Plc](https://whiteintel.dev/entity/afa0ea64-4121-5dbd-aad0-1867fb9df850) — 75–100% shares · corporate PSC · England — ceased 2019-06-24
- [Setfirst Limited](https://whiteintel.dev/entity/b2825d29-b940-410d-8d9b-0af637177e29) — 75–100% shares · corporate PSC · England — ceased 2019-05-31
- [Novartis Holding Ag](https://whiteintel.dev/entity/74adf261-3d63-4ed2-9b54-a073bcceaf7d) — 25–50% shares · corporate PSC · Switzerland — ceased 2018-06-01

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08998608
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08998608

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **HALEON UK HOLDINGS LIMITED** — https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HALEON UK HOLDINGS LIMITED**. Human view: https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137 · Structured JSON: https://whiteintel.dev/api/public/dossier/9a9412c4-bbf0-545c-b128-d5eba5dc2137._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._